IL-4 Deficiency Decreases Mortality but Increases Severity of Arthritis in Experimental Group B Streptococcus Infection
IL-4 is an anti-inflammatory cytokine that inhibits the onset and severity in different experimental arthritis models. Group B streptococci (GBS) have been recognized as an ever-growing cause of serious in...
Saved in:
Main Authors: | Luciana Tissi, Francesco Bistoni, Manuela Puliti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2009/394021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China
by: Yingxing Li, et al.
Published: (2025-01-01) -
Multiple Brain Abscesses due to Streptococcus anginosus: Prediction of Mortality by an Imaging Severity Index Score
by: K. O. Kragha
Published: (2016-01-01) -
Parapharyngeal Abscesses Caused by Group G Streptococcus
by: Shori Tajima, et al.
Published: (2018-01-01) -
pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
by: Sofia Fernanda Gonçalves Zorzella-Pezavento, et al.
Published: (2017-01-01) -
Osteomyelitis with a Twist: Streptococcus pneumoniae Causing Sternoclavicular Septic Arthritis
by: Ruchi Murthy, et al.
Published: (2015-01-01)